M.D. Sass LLC’s CBRE Group CBRE Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
Sell
-290,485
Closed -$39.3M 42
2026
Q1
$39.3M Sell
290,485
-5,252
-2% -$798K 2.98% 18
2025
Q4
$47.6M Buy
295,737
+2,068
+0.7% +$325K 3.75% 16
2025
Q3
$46.3M Sell
293,669
-102,900
-26% -$15.9M 3.77% 15
2025
Q2
$55.6M Buy
396,569
+19,152
+5% +$2.42M 4.47% 14
2025
Q1
$49.4M Sell
377,417
-7,804
-2% -$1.06M 4.34% 13
2024
Q4
$50.6M Sell
385,221
-85,006
-18% -$11.1M 3.81% 17
2024
Q3
$58.5M Sell
470,227
-70,917
-13% -$7.73M 4.33% 11
2024
Q2
$48.2M Buy
541,144
+198,994
+58% +$17.7M 3.46% 14
2024
Q1
$33.3M Buy
342,150
+7,697
+2% +$691K 3.75% 11
2023
Q4
$31.1M Buy
334,453
+102,929
+44% +$8M 3.74% 13
2023
Q3
$17.1M Sell
231,524
-59,461
-20% -$4.93M 2.3% 20
2023
Q2
$23.5M Buy
+290,985
New +$21.8M 3.11% 14

Other funds holding CBRE

M.D. Sass LLC's CBRE Position: Q2 2026 in Review

M.D. Sass LLC sold out of CBRE Group (CBRE) in Q2 2026, closing a stake of 290,485 shares — an estimated $39.3M sold.

M.D. Sass LLC first reported a position in CBRE in Q2 2023 and held it in 12 quarters. The position peaked at $58.5M in Q3 2024. 1,069 funds tracked by Wall St. Rank hold CBRE as of Q2 2026.

  • M.D. Sass LLC reported no remaining CBRE Group position as of Q2 2026 after selling out during the quarter.
  • M.D. Sass LLC sold 290,485 CBRE Group shares in Q2 2026, an estimated $39.3M.
  • M.D. Sass LLC first reported a position in CBRE Group in Q2 2023 and held it in 12 quarters.
  • M.D. Sass LLC's CBRE Group position peaked at $58.5M in Q3 2024.
  • 1,069 funds tracked by Wall St. Rank held CBRE Group as of Q2 2026.

Based on M.D. Sass LLC's 13F filing for Q2 2026, filed 7 Aug 2026.